What is Arcus Biosciences's EV / sales?

Arcus Biosciences (RCUS) reported EV / sales of 11.1× in Q1 2026.

How has Arcus Biosciences's EV / sales changed year-over-year?

Arcus Biosciences's EV / sales increased by 123.9% year-over-year, from 5× to 11.1×.

What is the long-term trend for Arcus Biosciences's EV / sales?

Over 5 years (2020 to 2025), Arcus Biosciences's EV / sales has grown at a -11.2% compound annual growth rate (CAGR), from 21.4× to 11.8×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Arcus Biosciences RCUS EV / sales

EV / sales at other companies

Bristol-Myers SquibbBMY

3.3×-0.1×

Merck & Co.MRK

5.2×+1.2×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

AbbVieABBV

7.5×+1.0×

IDEAYA Biosciences, Inc.IDYA

308×+215×

IncyteINCY

2.9×+0.6×

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

enterprise value/total revenue=11.1×

Based on the most recent quarter.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's EV / sales?: Arcus Biosciences (RCUS) reported EV / sales of 11.1× in Q1 2026.
How has Arcus Biosciences's EV / sales changed year-over-year?: Arcus Biosciences's EV / sales increased by 123.9% year-over-year, from 5× to 11.1×.
What is the long-term trend for Arcus Biosciences's EV / sales?: Over 5 years (2020 to 2025), Arcus Biosciences's EV / sales has grown at a -11.2% compound annual growth rate (CAGR), from 21.4× to 11.8×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.